MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AZD4547

CAS No. : 1035270-39-3

MCE 站：AZD4547

产品活性：AZD4547 是一种有效的 FGFR 家族抑制剂，作用于 FGFR1，FGFR2，FGFR3 和 FGFR4，IC₅₀ 分别为 0.2 nM，2.5 nM，1.8 nM 和 165 nM。

研究领域：Protein Tyrosine Kinase/RTK

作用靶点：FGFR

In Vitro: AZD4547 also inhibits recombinant VEGFR2 (KDR) kinase activity with an IC₅₀ of 24 nM. In KG1a, Sum52-PE, MCF7, ａnd KMS11 cell lines, AZD4547 potently inhibits autophosphorylation of FGFR1, 2, ａnd 3 tyrosine kinases (IC₅₀ values of 12, 2, ａnd 40 nM, respectively) ａnd displays weaker inhibition of FGFR4 cellular kinase activity (IC₅₀=142 nM). Significantly weaker inhibitory activity is observed versus cellular KDR ａnd IGFR ligand-induced phosphorylation (IC₅₀ values of 258 ａnd 828 nM, respectively), representing approximately 20- ａnd 70-fold selectivity over cellular FGFR1. Besides, AZD4547 potently inhibits FGFR phosphorylation ａnd downstream signaling affected through FRS2, PLCγ, ａnd MAPK at the cellular level.

In Vivo: Female SCID mice bearing KMS11 tumors are randomized ａnd treated chronically with AZD4547 at a range of well-tolerated doses. Oral AZD4547 treatment results in dose-dependent tumor growth inhibition. Twice daily administration of AZD4547 at 3 mg/kg gives statistically significant tumor growth inhibition of 53% (P<0.0005 by one-tailed t test) when compare with vehicle-treated controls, whereas doses of 12.5 mg/kg once daily ａnd 6.25 mg/kg twice daily results in complete tumor stasis (P<0.0001). A further efficacy study in the KG1a model with 12.5 mg/kg once daily AZD4547 results in 65% tumor growth inhibition (P=0.002).

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  Protein Tyrosine Kinase Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Reprogramming Compound Library  |  Anti-Lung Cancer Compound Library  |  SU 5402  |  Heparan Sulfate  |  PD173074  |  Formotin  |  Gandotinib  |  KW-2449  |  Ferulic acid  |  PD-166866  |  CP-547632  |  PP58  |  SUN11602  |  R1530  |  2,5-Dihydroxybenzoic acid  |  Tyrosine kinase-IN-1  |  PD-161570  |  ARQ 069  |  PD-089828  |  SM1-71  |  SU4984

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。